leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 23:47:21 - browse：345

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： PhRMA lawsuit over Medicare drug price negotiation tossed

focus

hotspot

WSS

A disappointing year of Humira biosimilars

Readout LOUD podcast: How biotech is using artificial intelligence

To avoid data mishandling cases, universities eye AI and other tools

Medicare Advantage proposed rates disappoint insurers

The high cost of giving birth even with insurance

BioAge raises $170M for combination therapy with Zepbound

hotspot

leisure time

focus

Tori Bowie and the unacceptable rates of Black maternal death

Continuity nursing helped my family in our darkest PICU moments

Apple is now the first public company to be valued at $3 trillion

Key House Republican on health care plans exit from Congress

State Dept. review finds Biden bears some blame for Afghanistan failures

The Readout: Gilead, Bernie Sanders, and other pharma news

United colonoscopy coverage change 'may cost lives,' doctors say

Key House Republican on health care plans exit from Congress

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How to save PrEP access — and even expand it

Wikipedia

'Revelatory' study finds a smoking impact that remains after quitting

Medicare Advantage proposed rates disappoint insurers

Guidelines to prevent youth baseball injuries need more muscle

BioMarin wins approval for gene therapy to treat hemophilia A

Anesthesiologist group: stop taking Ozempic before surgery

After affirmative action ruling, medical educators look to 'holistic review'

entertainment

focus

hotspot

knowledge